Article
Radionuclide selection influences imaging outcomes in immunoPET with a brain-penetrant anti-Aβ antibody
2025-06-03
Abstract excerpt
<h4>Background</h4> Bispecific antibodies exploiting receptor-mediated transcytosis offer a promising strategy to overcome limited blood-brain barrier permeability in Alzheimer’s disease (AD) therapy and imaging. Lecanemab-Fab8D3 (Lec-Fab8D3), a bispecific anti-amyloid beta (Aβ) antibody engineered for enhanced brain delivery, holds potential as a companion immunoPET imaging diagnostic with the novel lecanemab im...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 10ae505b-ebd8-538a-b653-6b6e1f804f63
- DOI
- 10.1101/2025.05.31.657140
